Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February

The B.1.1.7 variant of concern (VOC) is increasing in prevalence across Europe. Accurate estimation of disease severity associated with this VOC is critical for pandemic planning. We found increased risk of death for VOC compared with non-VOC cases in England (HR: 1.67 (95% CI: 1.34 - 2.09; P<.0001). Absolute risk of death by 28-days increased with age and comorbidities. VOC has potential to spread faster with higher mortality than the pandemic to date.

[1]  N. G. Davies,et al.  Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 , 2021, Nature.

[2]  P. Horby,et al.  Analysis of severe outcomes associated with the SARS-CoV-2 Variant of Concern 202012/01 in England using ICNARC Case Mix Programme and QResearch databases. , 2021, medRxiv.

[3]  G. Rodger,et al.  An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status , 2021, medRxiv.

[4]  L. Danon,et al.  Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study , 2021, BMJ.

[5]  N. Andrews,et al.  Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England , 2021, medRxiv.

[6]  G. Iacobucci,et al.  Covid-19: New UK variant may be linked to increased death rate, early data indicate , 2021, BMJ.

[7]  L. Smeeth,et al.  Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform , 2021, The Lancet Regional Health - Europe.

[8]  L. Smeeth,et al.  OpenSAFELY NHS Service Restoration Observatory 1: describing trends and variation in primary care clinical activity for 23.3 million patients in England during the first wave of COVID-19 , 2021, medRxiv.

[9]  Carl A. B. Pearson,et al.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.

[10]  L. Smeeth,et al.  UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records , 2020, BMC Public Health.

[11]  SARS-CoV-2 - increased circulation of variants of concern and vaccine rollout in the EU/EEA, 14th update , 2021 .

[12]  I. J. Douglas,et al.  OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. , 2020, medRxiv.

[13]  Investigation of novel SARS-COV-2 variant Variant of Concern 202012/01 , 2020 .

[14]  Lord Bourne,et al.  Department for Communities and Local Government: Troubled families programme: transforming the lives of thousands of families , 2016 .

[15]  R. Kay.  The Analysis of Survival Data , 2012 .

[16]  D.,et al.  Regression Models and Life-Tables , 2022 .